Kameelah Phillips, MD, FACOG, NCMP, discusses how health care providers (HCPs) can empower patients to advocate for their health during cervical cancer and sexually transmitted infection (STI) screenings by building trust, fostering open communication about sensitive topics, and striking a balance between sensitivity and thorough screening practices.
Genomic testing has grown in importance as the number of targeted anticancer therapies rises. Early genomic testing can help to guide treatment choices.
Hear from Jennifer Lincoln, MD, IBCLC, the OB hospitalist and lactation consultant whose TikTok posts have landed her nearly 2.5 million followers about the power of social media in health care.
In this recent interview, Bruce Kendall and Dr. Hinanit Koltai of the Volcani Institute share the inspiring story of the late Michelle Kendall and how her passion for science and research brought them all together to study medical cannabis as a potential treatment for ovarian cancer.
Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).
Moderna has initiated the rolling submission process for the biologics license application for its COVID-19 vaccine mRNA-1273.
Some of the essential characteristics of being a good communicator are to be concise, specific, pleasant, approachable, and most of all, to be a good listener.
The BRITE-MOM study at UCSF uses wearable ECGs to detect arrhythmias in pregnant women, aiming to improve early diagnosis and maternal cardiac outcomes.
What are the key factors of communication with a patient who is fearing symptom progression or near death?
The pandemic has forced us to get more creative in managing patients’ needs, especially when it comes to contraception
The phase 3 DESTINY-Breast04 trial using fam-trastuzumab deruxtecan-nxki showed a reduction in the risk of disease recurrence or death for patients with HER2-low, hormone receptor–positive metastatic breast cancer.
Providing clear and simple instructions reduces patients’ uncertainty and fear when confronted with bad news.
Data showed that fracture risk rises briefly after menopausal hormone therapy discontinuation, then falls below never-users.
Optimization of care represents a priority and requires an understanding of etiology to effectively diagnose and treat.
The monikers “new mother’s thumb” or “mother’s wrist” stem from the increased incidence of this disorder seen during the third trimester of pregnancy and in the first few months after delivery, especially if breastfeeding.
Three esteemed surgeons discuss technology, weighing the pros and cons of existing and newly developed platforms.
Findings and significance for gynecologic surgeons.
Panelists discuss how shortened hormone-free intervals (24-4 and 24-2-2 regimens) prevent ovarian reactivation and endometrial proliferation that caused breakthrough bleeding with traditional 21/7 formulations, while addressing how amenorrhea can be viewed as either a desired therapeutic outcome or concerning adverse effect depending on patient preferences.
A positive strategy to help patients with obesity is to help set realistic goals.
During the pandemic, physician self-care and organizational efforts to protect physician wellbeing are vital to maintaining a healthy and able workforce, which in turn enables a strong response to the ongoing health crisis.
Investigators argue that much of the language around women who give birth later in life is rooted in ableism and ageism and is out of step with current childbirth trends.
Mauricio Abrão, MD, and Jessica A. Shepherd, MD, MBA, FACOG, address gaps in care for the treatment of uterine fibroids and share the importance of patient education in disease management.
Here’s why we should be paying special attention to women’s depression treatment.
Substance use disorder may prove to be a significant issue for some mothers. In this article, experts discuss a case of addiction in pregnancy, analyzing the patient's medical history and psychosocial state.
A new study reveals how provider bias and stigma in reproductive health settings limit care for young, unmarried, and childless women—and how targeted interventions can help reduce these barriers.
Some research shows the previous guideline may have led to the under-treatment of patients with chronic pain.
A challenge in the prenatal management of FGR is differentiating the constitutionally small fetus with a normal neonatal outcome from one who is pathologically growth restricted and at risk for postnatal complications.